02:17 PM EDT, 05/28/2025 (MT Newswires) -- InflaRx ( IFRX ) shares sank 60% after the company said Wednesday it plans to discontinue development of vilobelimab in pyoderma gangrenosum, a rare and inflammatory skin disease.

More than 5.48 million shares traded intraday, compared with a daily average of about 301,000.

Cemtrex ( CETX ) said it priced a firm commitment underwritten public offering of 1.25 million shares at $1.00 apiece.

Shares slumped 46%, with intraday trading volume of over 2.56 million against a daily average of about 299,000.

Exodus Movement ( EXOD ) filed a registration statement late Tuesday for the sale of up to $1 billion of securities, including class A stock and debt, from time to time.

Shares dropped 21% as intraday trading volume rose to more than 220,000 from a daily average of roughly 96,000.

Price: 0.73, Change: -1.09, Percent Change: -59.89